悦康药业亮相BIO 2025，核酸多肽创新药管线点燃全球关注热潮

中国产业经济信...2025-07-01

近日，2025年美国生物技术大会暨展览会(BIO International Convention2025)在美国波士顿会展中心盛大举行。这场全球生物技术领域规模最大、专业性最强、影响力最广的行业盛会，以"The World Can’t Wait(世界不能等待)"为主题，汇聚了超20000名来自生物医药企业、学术机构、投资机构等不同领域的参会者与1500余家展商，聚焦AI、细胞与基因疗法等18个...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2548900578?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-01 18:51","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2548900578","market":"sh","top_or_hot":-1,"title":"悦康药业亮相BIO 2025，核酸多肽创新药管线点燃全球关注热潮","media":"中国产业经济信...","content":"<div>\n<p>近日，2025年美国生物技术大会暨展览会(BIO International Convention2025)在美国波士顿会展中心盛大举行。这场全球生物技术领域规模最大、专业性最强、影响力最广的行业盛会，以\"The World Can’t Wait(世界不能等待)\"为主题，汇聚了超20000名来自生物医药企业、学术机构、投资机构等不同领域的参会者与1500余家展商，聚焦AI、细胞与基因疗法等18个...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701185632a7284d36&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>悦康药业亮相BIO 2025，核酸多肽创新药管线点燃全球关注热潮</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n悦康药业亮相BIO 2025，核酸多肽创新药管线点燃全球关注热潮\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-01 18:51 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701185632a7284d36&s=b><strong>中国产业经济信...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，2025年美国生物技术大会暨展览会(BIO International Convention2025)在美国波士顿会展中心盛大举行。这场全球生物技术领域规模最大、专业性最强、影响力最广的行业盛会，以\"The World Can’t Wait(世界不能等待)\"为主题，汇聚了超20000名来自生物医药企业、学术机构、投资机构等不同领域的参会者与1500余家展商，聚焦AI、细胞与基因疗法等18个...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701185632a7284d36&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688658","symbol_name":"悦康药业","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701185632a7284d36&s=b","article_id":"2548900578","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701185632a7284d36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2548900578","pubTimestamp":1751367092,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"在这场国际舞台上，悦康药业凭借其在小核酸、多肽创新药领域的重磅管线惊艳亮相，成为备受关注的焦点。悦康药业携带多款具有全球first-in-class与best-in-class潜力的研发项目参展。这些技术平台是悦康药业创新研发的坚实后盾，为其在新药研发道路上不断突破提供了强大的支撑。此次参展，悦康药业不仅提升了自身的国际知名度，更通过与国际头部企业的深度战略对接，为加速推进研发管线的国际化开发与合作奠定了重要基础。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","688658":"悦康药业","BK0239":"医药制造"},"translate_title":"Yuekang Pharmaceutical debuted at BIO 2025, and its innovative nucleic acid and peptide drug pipeline ignited a boom of global attention","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"688658":1},"content_text":"近日，2025年美国生物技术大会暨展览会(BIO International Convention2025)在美国波士顿会展中心盛大举行。这场全球生物技术领域规模最大、专业性最强、影响力最广的行业盛会，以\"The World Can’t Wait(世界不能等待)\"为主题，汇聚了超20000名来自生物医药企业、学术机构、投资机构等不同领域的参会者与1500余家展商，聚焦AI、细胞与基因疗法等18个热点议题，共探行业未来发展方向。在这场国际舞台上，悦康药业凭借其在小核酸、多肽创新药领域的重磅管线惊艳亮相，成为备受关注的焦点。悦康药业携带多款具有全球first-in-class与best-in-class潜力的研发项目参展。在Company Presentation环节，公司BD总监韩少伟博士系统介绍了公司十一大领先技术平台的核心优势，以及在核酸多肽领域的创新布局。这些技术平台是悦康药业创新研发的坚实后盾，为其在新药研发道路上不断突破提供了强大的支撑。会议期间，悦康药业团队积极与国际一线MNC、Big Pharma、知名投行开展一对一深度洽谈。其中，YKYY015(PCSK9siRNA，用于治疗高胆固醇血症或混合型高脂血症)、YKYY013(HBV siRNA，致力于乙肝功能性治愈)、YKYY029(AGT siRNA，高血压)、YKYY032(Lp(a)siRNA，抗动脉硬化风险)、YKYY025(RSV mRNA疫苗)、YKYY026(VZV mRNA疫苗)以及YKYY017(病毒膜融合抑制剂多肽药物，广谱冠状病毒感染)等多个创新药项目引发了热烈讨论。这些项目具有显著的差异化优势，有望为相关疾病的治疗带来突破性进展。此次参展，悦康药业不仅提升了自身的国际知名度，更通过与国际头部企业的深度战略对接，为加速推进研发管线的国际化开发与合作奠定了重要基础。这意味着悦康药业的创新成果将有更广阔的发展空间，能够与全球资源深度融合，加速新药研发进程，让“中国智造”的突破性治疗方案更快地惠及全球患者。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2548900578","isCrawlerRequest":true}